Upper Facial Lines Study

You must be:

• 18 years of age or older (men and women of all ethnicities)
• In general good health, with no history of any medical condition that may place you at increased study risk
• Willing to complete in-clinic visits, exams, activities and procedures 
• At least 6 months past any prior botulinum neurotoxin treatment as of Study Day 1
• At least 3 to 18 months past certain other cosmetic procedures or treatments, including but not limited to dermabrasion, peels, permanent makeup, non-permanent HA fillers and energy-based facial treatments
• Have no history of treatments to the mid or upper face such as radiation, surgery, suspension threads, non-HA fillers, synthetic implants or fat transplantation
• Not pregnant or breastfeeding
• Able to meet all other eligibility requirements

You may qualify if you have moderate to severe:

Crow’s feet (lateral canthal lines), Forehead lines, and Frown lines (glabellar lines)

Participants will receive:

Study treatment with Botulinum Type A, related exams and follow-up.

About this study:

The M22-974 clinical trial is a prospective, multi-centre, open-label study to evaluate satisfaction and outcomes following administration of Botulinum Toxin Type A in subjects with upper facial lines (glabellar lines, lateral canthal lines and forehead lines).